Genmab A/S (GNMSF)
265.27
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
Genmab EPS Diluted (Quarterly) : 0.83 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ascendis Pharma A/S | 11.41 |
| Zealand Pharma A/S | -0.8738 |
| Bavarian Nordic A/S | 0.0115 |
| Bioporto A/S | -0.0042 |
| Evaxion AS | -0.4366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 53.00M |
| Revenue (Quarterly) | 896.00M |
| Total Expenses (Quarterly) | 843.00M |
| Enterprise Value | 20.12B |
| Gross Profit Margin (Quarterly) | 92.75% |
| Profit Margin (Quarterly) | 5.92% |
| Earnings Yield | 4.98% |
| Operating Earnings Yield | 7.62% |
| Normalized Earnings Yield | 5.893 |